There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To develop an improved sustained-release (SR) formulation of exenatide (a therapy
for patients with type 2 diabetes mellitus) in a biweekly dosage form with therapeutic
efficacy comparable to that achieved with twice-daily injections of the drug.